Listed

Hyperion Defi, Inc.

HYPDNasdaqCIK 1682639FinancialsFiscal year ends Dec 31

Reports and events: 245 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Hyperion Defi, Inc., Reports and events
FiledFormWhat it isAccession number
2023-05-1209:09 ET10-QQuarterly reportPeriod 2023-03-310001410578-23-001063
2023-05-1116:28 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-23-059164
2023-05-1118:28 ETDEF 14AProxy statementPeriod 2023-06-270001104659-23-058591
2023-05-0808:14 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-23-056880
2023-05-0116:32 ET10-K/AAnnual report, amendedPeriod 2022-12-310001104659-23-054420
2023-03-3109:43 ET10-KAnnual reportPeriod 2022-12-310001410578-23-000511
2023-03-3016:16 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-23-039153
2023-02-2816:18 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-23-026731
2023-02-1516:17 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-23-022400
2023-02-1316:06 ETSC 13D/AOwnership report, active investor, amended0001193125-23-035735
2023-01-3008:24 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-23-007731
2023-01-2419:07 ETSC 13D/AOwnership report, active investor, amended0001104659-23-005938
2022-12-1308:07 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-126464
2022-12-0808:14 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-22-125338
2022-11-2908:10 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-122648
2022-11-1412:05 ET10-QQuarterly reportPeriod 2022-09-300001410578-22-003306
2022-11-1016:24 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-117172
2022-11-0716:34 ET8-K1.02 Termination of a material agreement0001104659-22-115448
2022-10-2008:34 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-110120
2022-09-3008:12 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-22-104349
2022-08-1116:00 ET10-QQuarterly reportPeriod 2022-06-300001410578-22-002278
2022-08-1016:55 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-088674
2022-07-2709:05 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-22-082995
2022-07-0709:08 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-22-077920
2022-06-1706:30 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-22-072110
2022-06-0708:23 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-068789
2022-05-1314:07 ET10-QQuarterly reportPeriod 2022-03-310001410578-22-001443
2022-05-1217:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-059565
2022-05-1217:20 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-059563
2022-05-0208:51 ETDEF 14AProxy statementPeriod 2022-06-160001104659-22-054203
2022-04-0417:21 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-042318
2022-03-3014:42 ET10-KAnnual reportPeriod 2021-12-310001410578-22-000649
2022-03-2816:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-038762
2022-03-0908:41 ET8-K/A1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-031848
2022-03-0709:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-030903
2022-02-0816:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-013659
2022-02-0813:04 ETSC 13D/AOwnership report, active investor, amended0001214659-22-002032
2022-02-0708:46 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001104659-22-012277
2021-12-2706:06 ETSC 13D/AOwnership report, active investor, amended0001214659-21-013618
2021-12-1417:09 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001104659-21-149603
2021-12-0616:27 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-146795
2021-12-0317:20 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-21-146432
2021-11-1216:17 ET10-QQuarterly reportPeriod 2021-09-300001104659-21-138092
2021-11-1016:21 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-21-136957
2021-11-0516:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-135002
2021-10-2516:16 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-129510
2021-09-1508:00 ET8-K1.01 Entry into a material agreement0001104659-21-115696
2021-08-2406:03 ETSC 13D/AOwnership report, active investor, amended0001104659-21-108742
2021-08-1216:17 ET10-QQuarterly reportPeriod 2021-06-300001104659-21-104176
2021-08-1116:14 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-103470

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 10:51 ET. Listed shows no prices and gives no investment advice.